Aditxt: Edison Open House Healthcare 2022

Aditxt: Edison Open House Healthcare 2022

Aditxt — 2 videos in collection

More on this equity

Aditxt is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring.

• Tell us about the company’s product development strategy.
• Can you tell us about AditxtScore for COVID-19 and the information it provides that you wouldn’t get from either antigen or PCR testing?
• How has AditxtScore been received in the marketplace and which organisations are using the platform?
• Please update us on the situation around the emergency use application (EUA) for AditxtScore and how important this is for your business.
• What are some of the potential advantages of your Apoptotic DNA Immunotherapy (ADI)?
• Which milestones should investors focus on in the coming year?


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free